Park Ha Biological Technology Co., Ltd. (BYAH)

2.75 -2.14% (-0.06)

Over 5Y: -99.8%

2026-08-28
Style
Area Line Line with markersneeds a shorter window Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

5 000 10 000 15 000
2025 2026

Financials Annual

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
FY22 — Revenue: 1.9M FY22 — Operating Cash Flow: 1.4M FY22 — Free Cash Flow: 1.4M FY22 — Net Income: 191.3K FY23 — Revenue: 2.5M FY23 — Operating Cash Flow: 126.5K FY23 — Free Cash Flow: 103.9K FY23 — Net Income: 852K FY24 — Revenue: 2.4M FY24 — Operating Cash Flow: 960.5K FY24 — Free Cash Flow: 874.9K FY24 — Net Income: 478.6K FY25 — Revenue: 2.5M FY25 — Operating Cash Flow: 85.9K FY25 — Free Cash Flow: -3K FY25 — Net Income: -24.4M -24M -18M -12M -6M 0 6M
FY22 FY23 FY24 FY25
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2025-10-31, reported in USD. The newest fact in the filings is dated 2025-12-26, 247 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.7
SBC / sales 953.3%
OE margin -953.5%
Oper. margin -956.5%
ROIC -9208.4%
Accruals -410.8%
Gross margin 94.4%
FCF margin -0.12%
OCF margin 3.4%
EBITDA margin -952.1%
Profit margin -965.0%
ROA -409.3%
ROCE -593.2%
ROE -609.9%
OCF / EBIT —

5 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

2.8
RPO / sales 0.077×
Segment HHI 0.38 HHI
RPO growth —

4 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.5
ND/EBITDA —
Interest cover -588997.6×
Cash runway 1274.0 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 2.9×
F-score 4.5 pts
Cash / Debt —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

1.0
Sales/sh Y/Y -10.0%
EPS Y/Y -4422.4%
Shares change +17.8%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS next Y —
Sales CAGR 4Y —
Sales Q/Q —

3 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.